Alpha-2c-adrenergic receptors contribute to basal nasal patency in the anesthetized cat
- PMID: 20375536
- DOI: 10.1159/000284581
Alpha-2c-adrenergic receptors contribute to basal nasal patency in the anesthetized cat
Abstract
Background: Nasal congestion is the most troublesome symptom associated with a variety of upper airway diseases, including allergic rhinitis and the common cold. A better understanding of the mechanisms that regulate nasal cavity caliber may engender the development of novel treatment strategies. It is well accepted that alpha-adrenergic (both alpha(1) and alpha(2)) mechanisms play a fundamental role in the control and maintenance of basal nasal patency. JP-1302 is a selective alpha(2c)-subtype antagonist that has been recently described in the scientific literature. Thus, we sought to examine the potential effects of this new pharmacological tool on basal nasal patency.
Methods: Using acoustic rhinometry, we studied the activity of the selective alpha(2c)-antagonist JP-1302 on nasal cavity volumes in an anesthetized cat. Cumulative concentrations of JP-1302 were applied directly into the right nasal cavity. Changes in the nasal cavity geometry of the drug-treated naris relative to the untreated left nasal cavity were determined. In separate studies, the nonselective alpha(2)-antagonist yohimbine and the nonselective alpha(1)-antagonist prazosin were run as comparators. Systolic blood pressure was measured at the hind leg, using an ultrasonic Doppler flow detector.
Results: JP-1302 (0.03, 0.1, 0.3 and 1.0%) administered by the intranasal route decreased nasal cavity volumes from baseline values by 17, 25, 40 and 40%, respectively. Yohimbine (0.03, 0.1, 0.3 and 1.0%) decreased volumes by 19, 36, 46 and 53%, and topical administration of the nonselective alpha(1)-antagonist prazosin (0.001, 0.003, 0.01, 0.03 and 0.1%) decreased volumes by 6, 47, 56, 64 and 71%, respectively. JP-1302, yohimbine and prazosin, at the dose level tested, did not alter the blood pressure.
Conclusions: The present set of experiments indicates that both alpha(1)- and alpha(2)-adrenergic receptors are involved in the maintenance of basal nasal patency in the cat. Moreover, alpha(2c)-receptors may play a significant role in the sympathetic control of upper airway function.
Copyright 2010 S. Karger AG, Basel.
Similar articles
-
Intranasal application of the alpha2-adrenoceptor agonist BHT-920 produces decongestion in the cat.Am J Rhinol. 2001 Nov-Dec;15(6):407-15. Am J Rhinol. 2001. PMID: 11777250
-
Pharmacological analysis of the noradrenergic control of central sympathetic and somatic reflexes controlling the lower urinary tract in the anesthetized cat.J Pharmacol Exp Ther. 1995 Aug;274(2):820-5. J Pharmacol Exp Ther. 1995. PMID: 7636745
-
Sensory neuropeptides and nitric oxide in nasal vascular regulation.Acta Physiol Scand Suppl. 1996;632:1-45. Acta Physiol Scand Suppl. 1996. PMID: 8800374 Clinical Trial.
-
Renal vasodilation induced by hypernatraemia: role of alpha-adrenoceptors in the median preoptic nucleus.Clin Exp Pharmacol Physiol. 2009 Dec;36(12):e83-9. doi: 10.1111/j.1440-1681.2009.05280.x. Epub 2009 Aug 28. Clin Exp Pharmacol Physiol. 2009. PMID: 19719753
-
A model of allergic nasal congestion in dogs sensitized to ragweed.Am J Rhinol. 2003 Jul-Aug;17(4):227-32. Am J Rhinol. 2003. PMID: 12962193
Cited by
-
Scientific rationale for the use of alpha-adrenergic agonists and glucocorticoids in the therapy of pediatric stridor.Int J Otolaryngol. 2011;2011:575018. doi: 10.1155/2011/575018. Epub 2011 Dec 19. Int J Otolaryngol. 2011. PMID: 22220172 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous